Skip to main content

infliximab

 

Status: Under consideration by AWMSG Scrutiny Panel

For the off-label treatment of Immune Checkpoint Inhibitor (ICI) induced grade 3-4 myocarditis that has not responded to first line immunosuppression with corticosteroids.

Medicine details

Medicine name infliximab
Formulation powder for solution for infusion
Reference number 6460
Indication

As above

Company various
BNF chapter Malignant disease & immunosuppression
Status Under consideration by AWMSG Scrutiny Panel
Scrutiny Panel meeting date 06/03/2025
Follow AWTTC: